-
1
-
-
84872967522
-
Cancer statistics, 2013
-
10.3322/caac.21166, 23335087
-
Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013, 63(1):11-30. 10.3322/caac.21166, 23335087.
-
(2013)
CA Cancer J Clin
, vol.63
, Issue.1
, pp. 11-30
-
-
Siegel, R.1
Naishadham, D.2
Jemal, A.3
-
2
-
-
79953727024
-
From prostate to bone: key players in prostate cancer bone metastasis
-
3096870,3096870, 21603150
-
Thobe MN, Clark RJ, Bainer RO, Prasad SM, Rinker-Schaeffer CW. From prostate to bone: key players in prostate cancer bone metastasis. Cancers (Basel) 2011, 3(1):478-493. 3096870,3096870, 21603150.
-
(2011)
Cancers (Basel)
, vol.3
, Issue.1
, pp. 478-493
-
-
Thobe, M.N.1
Clark, R.J.2
Bainer, R.O.3
Prasad, S.M.4
Rinker-Schaeffer, C.W.5
-
3
-
-
79952232216
-
Global cancer statistics
-
10.3322/caac.20107, 21296855
-
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61(2):69-90. 10.3322/caac.20107, 21296855.
-
(2011)
CA Cancer J Clin
, vol.61
, Issue.2
, pp. 69-90
-
-
Jemal, A.1
Bray, F.2
Center, M.M.3
Ferlay, J.4
Ward, E.5
Forman, D.6
-
4
-
-
0034085989
-
Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients
-
10.1053/hp.2000.6698, 10836297
-
Bubendorf L, Schopfer A, Wagner U, Sauter G, Moch H, Willi N, Gasser TC, Mihatsch MJ. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol 2000, 31(5):578-583. 10.1053/hp.2000.6698, 10836297.
-
(2000)
Hum Pathol
, vol.31
, Issue.5
, pp. 578-583
-
-
Bubendorf, L.1
Schopfer, A.2
Wagner, U.3
Sauter, G.4
Moch, H.5
Willi, N.6
Gasser, T.C.7
Mihatsch, M.J.8
-
5
-
-
34248545487
-
Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption
-
10.1158/0008-5472.CAN-06-1210, 17440076
-
Lu Y, Cai Z, Xiao G, Keller ET, Mizokami A, Yao Z, Roodman GD, Zhang J. Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption. Cancer Res 2007, 67(8):3646-3653. 10.1158/0008-5472.CAN-06-1210, 17440076.
-
(2007)
Cancer Res
, vol.67
, Issue.8
, pp. 3646-3653
-
-
Lu, Y.1
Cai, Z.2
Xiao, G.3
Keller, E.T.4
Mizokami, A.5
Yao, Z.6
Roodman, G.D.7
Zhang, J.8
-
6
-
-
0030749321
-
Skeletal complications of malignancy
-
Coleman RE. Skeletal complications of malignancy. Cancer 1997, 80(8 Suppl):1588-1594.
-
(1997)
Cancer
, vol.80
, Issue.8 SUPPL.
, pp. 1588-1594
-
-
Coleman, R.E.1
-
7
-
-
0025850907
-
Mechanisms of osteolytic bone destruction
-
Mundy GR. Mechanisms of osteolytic bone destruction. Bone 1991, 12(Suppl 1):S1-S6.
-
(1991)
Bone
, vol.12
, Issue.SUPPL. 1
-
-
Mundy, G.R.1
-
8
-
-
0030036375
-
Biochemical evaluation of bone turnover in cancer patients with bone metastases: relationship with radiograph appearances and disease extension
-
10.1038/bjc.1996.298, 2074561, 8664134
-
Berruti A, Piovesan A, Torta M, Raucci CA, Gorzegno G, Paccotti P, Dogliotti L, Angeli A. Biochemical evaluation of bone turnover in cancer patients with bone metastases: relationship with radiograph appearances and disease extension. Br J Cancer 1996, 73(12):1581-1587. 10.1038/bjc.1996.298, 2074561, 8664134.
-
(1996)
Br J Cancer
, vol.73
, Issue.12
, pp. 1581-1587
-
-
Berruti, A.1
Piovesan, A.2
Torta, M.3
Raucci, C.A.4
Gorzegno, G.5
Paccotti, P.6
Dogliotti, L.7
Angeli, A.8
-
9
-
-
4043064387
-
Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications
-
10.1002/ijc.20314, 15252851
-
Jung K, Lein M, Stephan C, von Hosslin K, Semjonow A, Sinha P, Loening SA, Schnorr D. Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications. Int J Cancer 2004, 111(5):783-791. 10.1002/ijc.20314, 15252851.
-
(2004)
Int J Cancer
, vol.111
, Issue.5
, pp. 783-791
-
-
Jung, K.1
Lein, M.2
Stephan, C.3
von Hosslin, K.4
Semjonow, A.5
Sinha, P.6
Loening, S.A.7
Schnorr, D.8
-
10
-
-
0020664851
-
Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma special reference to osteomalacia
-
10.1002/1097-0142(19830301)51:5<918::AID-CNCR2820510526>3.0.CO;2-J, 6681595
-
Charhon SA, Chapuy MC, Delvin EE, Valentin-Opran A, Edouard CM, Meunier PJ. Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma special reference to osteomalacia. Cancer 1983, 51(5):918-924. 10.1002/1097-0142(19830301)51:5<918::AID-CNCR2820510526>3.0.CO;2-J, 6681595.
-
(1983)
Cancer
, vol.51
, Issue.5
, pp. 918-924
-
-
Charhon, S.A.1
Chapuy, M.C.2
Delvin, E.E.3
Valentin-Opran, A.4
Edouard, C.M.5
Meunier, P.J.6
-
11
-
-
0025863947
-
Morphometric evidence for bone resorption and replacement in prostate cancer
-
10.1111/j.1464-410X.1991.tb15260.x, 1873694
-
Clarke NW, McClure J, George NJ. Morphometric evidence for bone resorption and replacement in prostate cancer. Br J Urol 1991, 68(1):74-80. 10.1111/j.1464-410X.1991.tb15260.x, 1873694.
-
(1991)
Br J Urol
, vol.68
, Issue.1
, pp. 74-80
-
-
Clarke, N.W.1
McClure, J.2
George, N.J.3
-
12
-
-
16444368652
-
Osteoprotegerin in prostate cancer bone metastasis
-
10.1158/0008-5472.CAN-04-2033, 15753366
-
Corey E, Brown LG, Kiefer JA, Quinn JE, Pitts TE, Blair JM, Vessella RL. Osteoprotegerin in prostate cancer bone metastasis. Cancer Res 2005, 65(5):1710-1718. 10.1158/0008-5472.CAN-04-2033, 15753366.
-
(2005)
Cancer Res
, vol.65
, Issue.5
, pp. 1710-1718
-
-
Corey, E.1
Brown, L.G.2
Kiefer, J.A.3
Quinn, J.E.4
Pitts, T.E.5
Blair, J.M.6
Vessella, R.L.7
-
13
-
-
84886747695
-
Osteoclast fusion and regulation by RANKL-dependent and independent factors
-
10.5312/wjo.v3.i12.212, 3557323, 23362465
-
Xing L, Xiu Y, Boyce BF. Osteoclast fusion and regulation by RANKL-dependent and independent factors. World J Orthop 2012, 3(12):212-222. 10.5312/wjo.v3.i12.212, 3557323, 23362465.
-
(2012)
World J Orthop
, vol.3
, Issue.12
, pp. 212-222
-
-
Xing, L.1
Xiu, Y.2
Boyce, B.F.3
-
14
-
-
84875306158
-
Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclasts
-
10.1002/jbmr.1885, 23436579
-
Boyce BF. Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclasts. J Bone Miner Res 2013, 28(4):711-722. 10.1002/jbmr.1885, 23436579.
-
(2013)
J Bone Miner Res
, vol.28
, Issue.4
, pp. 711-722
-
-
Boyce, B.F.1
-
15
-
-
0033168518
-
Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function
-
Jimi E, Akiyama S, Tsurukai T, Okahashi N, Kobayashi K, Udagawa N, Nishihara T, Takahashi N, Suda T. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J Immunol 1999, 163(1):434-442.
-
(1999)
J Immunol
, vol.163
, Issue.1
, pp. 434-442
-
-
Jimi, E.1
Akiyama, S.2
Tsurukai, T.3
Okahashi, N.4
Kobayashi, K.5
Udagawa, N.6
Nishihara, T.7
Takahashi, N.8
Suda, T.9
-
16
-
-
0032540319
-
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
-
10.1016/S0092-8674(00)81569-X, 9568710
-
Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998, 93(2):165-176. 10.1016/S0092-8674(00)81569-X, 9568710.
-
(1998)
Cell
, vol.93
, Issue.2
, pp. 165-176
-
-
Lacey, D.L.1
Timms, E.2
Tan, H.L.3
Kelley, M.J.4
Dunstan, C.R.5
Burgess, T.6
Elliott, R.7
Colombero, A.8
Elliott, G.9
Scully, S.10
-
17
-
-
84867142035
-
New insights into osteoclastogenic signaling mechanisms
-
10.1016/j.tem.2012.05.005, 22705116
-
Nakashima T, Hayashi M, Takayanagi H. New insights into osteoclastogenic signaling mechanisms. Trends Endocrinol Metab 2012, 23(11):582-590. 10.1016/j.tem.2012.05.005, 22705116.
-
(2012)
Trends Endocrinol Metab
, vol.23
, Issue.11
, pp. 582-590
-
-
Nakashima, T.1
Hayashi, M.2
Takayanagi, H.3
-
18
-
-
85003186936
-
Transforming growth factor-beta gene family members and bone
-
Centrella M, Horowitz MC, Wozney JM, McCarthy TL. Transforming growth factor-beta gene family members and bone. Endocr Rev 1994, 15(1):27-39.
-
(1994)
Endocr Rev
, vol.15
, Issue.1
, pp. 27-39
-
-
Centrella, M.1
Horowitz, M.C.2
Wozney, J.M.3
McCarthy, T.L.4
-
19
-
-
0028824735
-
Transforming growth factor beta 1 stimulates bone formation and resorption in an in-vivo model in rabbits
-
Zhou H, Choong PC, Chou ST, Kartsogiannis V, Martin TJ, Ng KW. Transforming growth factor beta 1 stimulates bone formation and resorption in an in-vivo model in rabbits. Bone 1995, 17(4 Suppl):443S-448S.
-
(1995)
Bone
, vol.17
, Issue.4 SUPPL.
-
-
Zhou, H.1
Choong, P.C.2
Chou, S.T.3
Kartsogiannis, V.4
Martin, T.J.5
Ng, K.W.6
-
20
-
-
0942300653
-
Transforming growth factor-beta induces osteoclast formation in the absence of RANKL
-
10.1016/j.bone.2003.08.008, 14751563
-
Itonaga I, Sabokbar A, Sun SG, Kudo O, Danks L, Ferguson D, Fujikawa Y, Athanasou NA. Transforming growth factor-beta induces osteoclast formation in the absence of RANKL. Bone 2004, 34(1):57-64. 10.1016/j.bone.2003.08.008, 14751563.
-
(2004)
Bone
, vol.34
, Issue.1
, pp. 57-64
-
-
Itonaga, I.1
Sabokbar, A.2
Sun, S.G.3
Kudo, O.4
Danks, L.5
Ferguson, D.6
Fujikawa, Y.7
Athanasou, N.A.8
-
21
-
-
0035021176
-
Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone
-
10.1172/JCI11685, 209296, 11375413
-
Zhang J, Dai J, Qi Y, Lin DL, Smith P, Strayhorn C, Mizokami A, Fu Z, Westman J, Keller ET. Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone. J Clin Invest 2001, 107(10):1235-1244. 10.1172/JCI11685, 209296, 11375413.
-
(2001)
J Clin Invest
, vol.107
, Issue.10
, pp. 1235-1244
-
-
Zhang, J.1
Dai, J.2
Qi, Y.3
Lin, D.L.4
Smith, P.5
Strayhorn, C.6
Mizokami, A.7
Fu, Z.8
Westman, J.9
Keller, E.T.10
-
22
-
-
69049105440
-
Denosumab in men receiving androgen-deprivation therapy for prostate cancer
-
10.1056/NEJMoa0809003, 3038121, 19671656
-
Smith MR, Egerdie B, Hernandez Toriz N, Feldman R, Tammela TL, Saad F, Heracek J, Szwedowski M, Ke C, Kupic A, et al. Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Engl J Med 2009, 361(8):745-755. 10.1056/NEJMoa0809003, 3038121, 19671656.
-
(2009)
N Engl J Med
, vol.361
, Issue.8
, pp. 745-755
-
-
Smith, M.R.1
Egerdie, B.2
Hernandez Toriz, N.3
Feldman, R.4
Tammela, T.L.5
Saad, F.6
Heracek, J.7
Szwedowski, M.8
Ke, C.9
Kupic, A.10
-
23
-
-
79952614068
-
The role of RANK-ligand inhibition in cancer: the story of denosumab
-
10.1634/theoncologist.2010-0154, 3228090, 21285392
-
Castellano D, Sepulveda JM, Garcia-Escobar I, Rodriguez-Antolin A, Sundlov A, Cortes-Funes H. The role of RANK-ligand inhibition in cancer: the story of denosumab. Oncologist 2011, 16(2):136-145. 10.1634/theoncologist.2010-0154, 3228090, 21285392.
-
(2011)
Oncologist
, vol.16
, Issue.2
, pp. 136-145
-
-
Castellano, D.1
Sepulveda, J.M.2
Garcia-Escobar, I.3
Rodriguez-Antolin, A.4
Sundlov, A.5
Cortes-Funes, H.6
-
24
-
-
0037009822
-
A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma
-
10.1093/jnci/94.19.1458, 12359855
-
Saad F, Gleason DM, Murray R, Tchekmedyian S, Venner P, Lacombe L, Chin JL, Vinholes JJ, Goas JA, Chen B. A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. J Natl Cancer Inst 2002, 94(19):1458-1468. 10.1093/jnci/94.19.1458, 12359855.
-
(2002)
J Natl Cancer Inst
, vol.94
, Issue.19
, pp. 1458-1468
-
-
Saad, F.1
Gleason, D.M.2
Murray, R.3
Tchekmedyian, S.4
Venner, P.5
Lacombe, L.6
Chin, J.L.7
Vinholes, J.J.8
Goas, J.A.9
Chen, B.10
-
25
-
-
84872283943
-
Management of bone metastases in refractory prostate cancer-role of denosumab
-
3459574, 23049248
-
Paller CJ, Carducci MA, Philips GK. Management of bone metastases in refractory prostate cancer-role of denosumab. Clin Interv Aging 2012, 7:363-372. 3459574, 23049248.
-
(2012)
Clin Interv Aging
, vol.7
, pp. 363-372
-
-
Paller, C.J.1
Carducci, M.A.2
Philips, G.K.3
-
26
-
-
0033561535
-
Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone
-
Nemeth JA, Harb JF, Barroso U, He Z, Grignon DJ, Cher ML. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone. Cancer Res 1999, 59(8):1987-1993.
-
(1999)
Cancer Res
, vol.59
, Issue.8
, pp. 1987-1993
-
-
Nemeth, J.A.1
Harb, J.F.2
Barroso, U.3
He, Z.4
Grignon, D.J.5
Cher, M.L.6
-
27
-
-
13044316551
-
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand
-
10.1073/pnas.96.7.3540, 22329, 10097072
-
Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, Tan HL, Elliott G, Kelley MJ, Sarosi I, et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 1999, 96(7):3540-3545. 10.1073/pnas.96.7.3540, 22329, 10097072.
-
(1999)
Proc Natl Acad Sci USA
, vol.96
, Issue.7
, pp. 3540-3545
-
-
Hsu, H.1
Lacey, D.L.2
Dunstan, C.R.3
Solovyev, I.4
Colombero, A.5
Timms, E.6
Tan, H.L.7
Elliott, G.8
Kelley, M.J.9
Sarosi, I.10
-
28
-
-
78650972753
-
Breast cancer cells inhibit spontaneous and bisphosphonate-induced osteoclast apoptosis
-
10.1016/j.bone.2010.09.006, 20849994
-
Hussein O, Tiedemann K, Komarova SV. Breast cancer cells inhibit spontaneous and bisphosphonate-induced osteoclast apoptosis. Bone 2011, 48(2):202-211. 10.1016/j.bone.2010.09.006, 20849994.
-
(2011)
Bone
, vol.48
, Issue.2
, pp. 202-211
-
-
Hussein, O.1
Tiedemann, K.2
Komarova, S.V.3
-
29
-
-
21044447090
-
Prostate cancer mediates osteoclastogenesis through two different pathways
-
10.1016/j.canlet.2004.09.053, 15890244
-
Inoue H, Nishimura K, Oka D, Nakai Y, Shiba M, Tokizane T, Arai Y, Nakayama M, Shimizu K, Takaha N, et al. Prostate cancer mediates osteoclastogenesis through two different pathways. Cancer Lett 2005, 223(1):121-128. 10.1016/j.canlet.2004.09.053, 15890244.
-
(2005)
Cancer Lett
, vol.223
, Issue.1
, pp. 121-128
-
-
Inoue, H.1
Nishimura, K.2
Oka, D.3
Nakai, Y.4
Shiba, M.5
Tokizane, T.6
Arai, Y.7
Nakayama, M.8
Shimizu, K.9
Takaha, N.10
-
30
-
-
18744366041
-
Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts
-
10.1016/S1534-5807(02)00369-6, 12479813
-
Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 2002, 3(6):889-901. 10.1016/S1534-5807(02)00369-6, 12479813.
-
(2002)
Dev Cell
, vol.3
, Issue.6
, pp. 889-901
-
-
Takayanagi, H.1
Kim, S.2
Koga, T.3
Nishina, H.4
Isshiki, M.5
Yoshida, H.6
Saiura, A.7
Isobe, M.8
Yokochi, T.9
Inoue, J.10
-
31
-
-
70450228430
-
Breast cancer-derived factors stimulate osteoclastogenesis through the Ca2+/protein kinase C and transforming growth factor-beta/MAPK signaling pathways
-
10.1074/jbc.M109.010785, 2785208, 19801662
-
Tiedemann K, Hussein O, Sadvakassova G, Guo Y, Siegel PM, Komarova SV. Breast cancer-derived factors stimulate osteoclastogenesis through the Ca2+/protein kinase C and transforming growth factor-beta/MAPK signaling pathways. J Biol Chem 2009, 284(48):33662-33670. 10.1074/jbc.M109.010785, 2785208, 19801662.
-
(2009)
J Biol Chem
, vol.284
, Issue.48
, pp. 33662-33670
-
-
Tiedemann, K.1
Hussein, O.2
Sadvakassova, G.3
Guo, Y.4
Siegel, P.M.5
Komarova, S.V.6
-
32
-
-
0037174944
-
Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator
-
10.1074/jbc.M205063200, 12171919
-
Ishida N, Hayashi K, Hoshijima M, Ogawa T, Koga S, Miyatake Y, Kumegawa M, Kimura T, Takeya T. Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J Biol Chem 2002, 277(43):41147-41156. 10.1074/jbc.M205063200, 12171919.
-
(2002)
J Biol Chem
, vol.277
, Issue.43
, pp. 41147-41156
-
-
Ishida, N.1
Hayashi, K.2
Hoshijima, M.3
Ogawa, T.4
Koga, S.5
Miyatake, Y.6
Kumegawa, M.7
Kimura, T.8
Takeya, T.9
-
33
-
-
52449084680
-
Osteoclast precursors acquire sensitivity to breast cancer derived factors early in differentiation
-
10.1016/j.bone.2008.03.026, 18502714
-
Guo Y, Tiedemann K, Khalil JA, Russo C, Siegel PM, Komarova SV. Osteoclast precursors acquire sensitivity to breast cancer derived factors early in differentiation. Bone 2008, 43(2):386-393. 10.1016/j.bone.2008.03.026, 18502714.
-
(2008)
Bone
, vol.43
, Issue.2
, pp. 386-393
-
-
Guo, Y.1
Tiedemann, K.2
Khalil, J.A.3
Russo, C.4
Siegel, P.M.5
Komarova, S.V.6
-
34
-
-
0036138694
-
The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation
-
10.1016/S8756-3282(01)00657-3, 11792567
-
Lee SE, Woo KM, Kim SY, Kim HM, Kwack K, Lee ZH, Kim HH. The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation. Bone 2002, 30(1):71-77. 10.1016/S8756-3282(01)00657-3, 11792567.
-
(2002)
Bone
, vol.30
, Issue.1
, pp. 71-77
-
-
Lee, S.E.1
Woo, K.M.2
Kim, S.Y.3
Kim, H.M.4
Kwack, K.5
Lee, Z.H.6
Kim, H.H.7
-
35
-
-
33745821237
-
Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation
-
10.1002/cncr.21978, 16752412
-
Chen G, Sircar K, Aprikian A, Potti A, Goltzman D, Rabbani SA. Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation. Cancer 2006, 107(2):289-298. 10.1002/cncr.21978, 16752412.
-
(2006)
Cancer
, vol.107
, Issue.2
, pp. 289-298
-
-
Chen, G.1
Sircar, K.2
Aprikian, A.3
Potti, A.4
Goltzman, D.5
Rabbani, S.A.6
-
36
-
-
7244243811
-
Heterogeneity in primary and metastatic prostate cancer as defined by cell surface CD profile
-
10.1016/S0002-9440(10)63412-8, 1618667, 15509525
-
Liu AY, Roudier MP, True LD. Heterogeneity in primary and metastatic prostate cancer as defined by cell surface CD profile. Am J Pathol 2004, 165(5):1543-1556. 10.1016/S0002-9440(10)63412-8, 1618667, 15509525.
-
(2004)
Am J Pathol
, vol.165
, Issue.5
, pp. 1543-1556
-
-
Liu, A.Y.1
Roudier, M.P.2
True, L.D.3
-
37
-
-
0035724236
-
Characterization of cultured human prostatic epithelial cells by cluster designation antigen expression
-
10.1007/s004410100419, 11572092
-
Liu AY, Peehl DM. Characterization of cultured human prostatic epithelial cells by cluster designation antigen expression. Cell Tissue Res 2001, 305(3):389-397. 10.1007/s004410100419, 11572092.
-
(2001)
Cell Tissue Res
, vol.305
, Issue.3
, pp. 389-397
-
-
Liu, A.Y.1
Peehl, D.M.2
-
38
-
-
84874585723
-
New insights into prostate cancer stem cells
-
10.4161/cc.23721, 23370446
-
Chen X, Rycaj K, Liu X, Tang DG. New insights into prostate cancer stem cells. Cell Cycle 2013, 12(4):579-586. 10.4161/cc.23721, 23370446.
-
(2013)
Cell Cycle
, vol.12
, Issue.4
, pp. 579-586
-
-
Chen, X.1
Rycaj, K.2
Liu, X.3
Tang, D.G.4
-
39
-
-
28544446111
-
Monocyte and macrophage heterogeneity
-
10.1038/nri1733, 16322748
-
Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005, 5(12):953-964. 10.1038/nri1733, 16322748.
-
(2005)
Nat Rev Immunol
, vol.5
, Issue.12
, pp. 953-964
-
-
Gordon, S.1
Taylor, P.R.2
-
40
-
-
79959244877
-
CCN3 impairs osteoblast and stimulates osteoclast differentiation to favor breast cancer metastasis to bone
-
10.1016/j.ajpath.2011.01.033, 3081179, 21514448
-
Ouellet V, Tiedemann K, Mourskaia A, Fong JE, Tran-Thanh D, Amir E, Clemons M, Perbal B, Komarova SV, Siegel PM. CCN3 impairs osteoblast and stimulates osteoclast differentiation to favor breast cancer metastasis to bone. Am J Pathol 2011, 178(5):2377-2388. 10.1016/j.ajpath.2011.01.033, 3081179, 21514448.
-
(2011)
Am J Pathol
, vol.178
, Issue.5
, pp. 2377-2388
-
-
Ouellet, V.1
Tiedemann, K.2
Mourskaia, A.3
Fong, J.E.4
Tran-Thanh, D.5
Amir, E.6
Clemons, M.7
Perbal, B.8
Komarova, S.V.9
Siegel, P.M.10
-
41
-
-
57449108869
-
Influence of simultaneous targeting of the bone morphogenetic protein pathway and RANK/RANKL axis in osteolytic prostate cancer lesion in bone
-
10.1016/j.bone.2008.09.009, 2657045, 18929692
-
Virk MS, Petrigliano FA, Liu NQ, Chatziioannou AF, Stout D, Kang CO, Dougall WC, Lieberman JR. Influence of simultaneous targeting of the bone morphogenetic protein pathway and RANK/RANKL axis in osteolytic prostate cancer lesion in bone. Bone 2009, 44(1):160-167. 10.1016/j.bone.2008.09.009, 2657045, 18929692.
-
(2009)
Bone
, vol.44
, Issue.1
, pp. 160-167
-
-
Virk, M.S.1
Petrigliano, F.A.2
Liu, N.Q.3
Chatziioannou, A.F.4
Stout, D.5
Kang, C.O.6
Dougall, W.C.7
Lieberman, J.R.8
-
42
-
-
83755225707
-
The osteoclast and its unique cytoskeleton
-
10.1111/j.1749-6632.2011.06283.x, 22172034
-
Teitelbaum SL. The osteoclast and its unique cytoskeleton. Ann N Y Acad Sci 2011, 1240:14-17. 10.1111/j.1749-6632.2011.06283.x, 22172034.
-
(2011)
Ann N Y Acad Sci
, vol.1240
, pp. 14-17
-
-
Teitelbaum, S.L.1
-
43
-
-
83755186547
-
How are osteoclasts induced to resorb bone?
-
10.1111/j.1749-6632.2011.06249.x, 22172032
-
Chambers TJ, Fuller K. How are osteoclasts induced to resorb bone?. Ann N Y Acad Sci 2011, 1240:1-6. 10.1111/j.1749-6632.2011.06249.x, 22172032.
-
(2011)
Ann N Y Acad Sci
, vol.1240
, pp. 1-6
-
-
Chambers, T.J.1
Fuller, K.2
-
44
-
-
79953326119
-
Steps in prostate cancer progression that lead to bone metastasis
-
10.1002/ijc.26024, 3082284, 21365645
-
Jin JK, Dayyani F, Gallick GE. Steps in prostate cancer progression that lead to bone metastasis. Int J Cancer 2011, 128(11):2545-2561. 10.1002/ijc.26024, 3082284, 21365645.
-
(2011)
Int J Cancer
, vol.128
, Issue.11
, pp. 2545-2561
-
-
Jin, J.K.1
Dayyani, F.2
Gallick, G.E.3
-
45
-
-
79961038278
-
Blockade of transforming growth factor-beta (TGFbeta) signaling inhibits osteoblastic tumorigenesis by a novel human prostate cancer cell line
-
10.1002/pros.21361, 3108007, 21321980
-
Mishra S, Tang Y, Wang L, deGraffenried L, Yeh IT, Werner S, Troyer D, Copland JA, Sun LZ. Blockade of transforming growth factor-beta (TGFbeta) signaling inhibits osteoblastic tumorigenesis by a novel human prostate cancer cell line. Prostate 2011, 71(13):1441-1454. 10.1002/pros.21361, 3108007, 21321980.
-
(2011)
Prostate
, vol.71
, Issue.13
, pp. 1441-1454
-
-
Mishra, S.1
Tang, Y.2
Wang, L.3
deGraffenried, L.4
Yeh, I.T.5
Werner, S.6
Troyer, D.7
Copland, J.A.8
Sun, L.Z.9
-
46
-
-
33645897313
-
Prostate cancer cells regulate growth and differentiation of bone marrow endothelial cells through TGFbeta and its receptor, TGFbetaRII
-
10.1002/pros.20370, 16388503
-
Barrett JM, Rovedo MA, Tajuddin AM, Jilling T, Macoska JA, MacDonald J, Mangold KA, Kaul KL. Prostate cancer cells regulate growth and differentiation of bone marrow endothelial cells through TGFbeta and its receptor, TGFbetaRII. Prostate 2006, 66(6):632-650. 10.1002/pros.20370, 16388503.
-
(2006)
Prostate
, vol.66
, Issue.6
, pp. 632-650
-
-
Barrett, J.M.1
Rovedo, M.A.2
Tajuddin, A.M.3
Jilling, T.4
Macoska, J.A.5
MacDonald, J.6
Mangold, K.A.7
Kaul, K.L.8
-
47
-
-
0036877421
-
Alterations of expression and regulation of transforming growth factor beta in human cancer prostate cell lines
-
Blanchere M, Saunier E, Mestayer C, Broshuis M, Mowszowicz I. Alterations of expression and regulation of transforming growth factor beta in human cancer prostate cell lines. J Steroid Biochem Mol Biol 2002, 82(4-5):297-304.
-
(2002)
J Steroid Biochem Mol Biol
, vol.82
, Issue.4-5
, pp. 297-304
-
-
Blanchere, M.1
Saunier, E.2
Mestayer, C.3
Broshuis, M.4
Mowszowicz, I.5
-
48
-
-
0027368962
-
Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts
-
10.1084/jem.178.5.1733, 2191238, 8228819
-
Fuller K, Owens JM, Jagger CJ, Wilson A, Moss R, Chambers TJ. Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J Exp Med 1993, 178(5):1733-1744. 10.1084/jem.178.5.1733, 2191238, 8228819.
-
(1993)
J Exp Med
, vol.178
, Issue.5
, pp. 1733-1744
-
-
Fuller, K.1
Owens, J.M.2
Jagger, C.J.3
Wilson, A.4
Moss, R.5
Chambers, T.J.6
-
49
-
-
79959674553
-
M-CSF potently augments RANKL-induced resorption activation in mature human osteoclasts
-
10.1371/journal.pone.0021462, 3126821, 21738673
-
Hodge JM, Collier FM, Pavlos NJ, Kirkland MA, Nicholson GC. M-CSF potently augments RANKL-induced resorption activation in mature human osteoclasts. PLoS One 2011, 6(6):e21462. 10.1371/journal.pone.0021462, 3126821, 21738673.
-
(2011)
PLoS One
, vol.6
, Issue.6
-
-
Hodge, J.M.1
Collier, F.M.2
Pavlos, N.J.3
Kirkland, M.A.4
Nicholson, G.C.5
-
50
-
-
0346525140
-
U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells
-
10.1074/jbc.M208284200, 12237315
-
Hotokezaka H, Sakai E, Kanaoka K, Saito K, Matsuo K, Kitaura H, Yoshida N, Nakayama K. U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells. J Biol Chem 2002, 277(49):47366-47372. 10.1074/jbc.M208284200, 12237315.
-
(2002)
J Biol Chem
, vol.277
, Issue.49
, pp. 47366-47372
-
-
Hotokezaka, H.1
Sakai, E.2
Kanaoka, K.3
Saito, K.4
Matsuo, K.5
Kitaura, H.6
Yoshida, N.7
Nakayama, K.8
-
51
-
-
80053058791
-
Erk1 positively regulates osteoclast differentiation and bone resorptive activity
-
10.1371/journal.pone.0024780, 3178550, 21961044
-
He Y, Staser K, Rhodes SD, Liu Y, Wu X, Park SJ, Yuan J, Yang X, Li X, Jiang L, et al. Erk1 positively regulates osteoclast differentiation and bone resorptive activity. PLoS One 2011, 6(9):e24780. 10.1371/journal.pone.0024780, 3178550, 21961044.
-
(2011)
PLoS One
, vol.6
, Issue.9
-
-
He, Y.1
Staser, K.2
Rhodes, S.D.3
Liu, Y.4
Wu, X.5
Park, S.J.6
Yuan, J.7
Yang, X.8
Li, X.9
Jiang, L.10
|